AFP and hepatocellular carcinoma: The TBA-MLR score is a novel and efficient metabolic-immune prognostic tool that effectively identifies high-risk biology occult within conventional HCC staging systems, particularly in BCLC 0-A and AFP <400 ng/mL patients.